The size of the Middle East and Africa Vascular Closure Devices Market was worth USD 0.66 billion in 2022 and is estimated to be growing at a CAGR of 5.5%, to reach USD 0.87 billion by 2027.
Vascular closure devices are the devices that are used to stop the blood flow from the puncture made on the femoral artery after certain diagnostic procedures. For example, large incisions are required for cardiovascular surgeries to replace valves in the heart.
Manual compression is not a good option during these surgeries. Vascular closure devices increase comfort and reduce discharge time for patients, and they can be used with ease. They reduce a lot of time and effort for physicians, and further supervision is not required. Technological advancements resulted in novel materials that degrade after a short period of time.
Increasing awareness of minimally invasive surgeries, a rising number of angiography procedures, the large geriatric population who require valve replacements are the major factors driving the market. In addition, technological advancements and the ease with which VCDs can be used are also propelling the market.
However, certain risks involving VCDs, such as groin infections and other disadvantages, and rising costs of devices, are restraining the market.
This research report on the MEA vascular closure devices market has been segmented and sub-segmented into the following categories:
By Type:
By Access:
By Procedure:
By End User:
By Country:
Regionally, the rising prevalence of cancer and the increasing focus of major players to expand in this region are expected to drive the market in this region.
KEY MARKET PLAYERS:
Biotronik GMBH & CO.KG, Abbott Vascular, Cardinal Health, Merit Medical Systems, Inc., Medtronic, Cardival Medical, Inc., Boston Scientific Corporation, Essential Medical, Inc., W L. Gore & Associates; St. Jude Medical, TZ Medical, Inc., and Scion BioMedical are prominent companies operating in the MEA vascular closure devices market.
1.Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Type
5.1.1 Introduction
5.1.2 Passive Approximators
5.1.2.1 Collagen Plugs
5.1.2.2 Sealant or Gel based Devices
5.1.2.3 Compression Assist Devices
5.1.3 Active Approximators
5.1.3.1 Suture-Based Devices
5.1.3.2 Clip-Based Devices
5.1.4 External Hemostatic Devices
5.1.5 Y-o-Y Growth Analysis, By Type
5.1.6 Market Attractiveness Analysis, By Type
5.1.7 Market Share Analysis, By Type
5.2 Access
5.2.1 Introduction
5.2.2 Femoral Access
5.2.3 Radial Access
5.2.4 Y-o-Y Growth Analysis, By Access
5.2.5 Market Attractiveness Analysis, By Access
5.2.6 Market Share Analysis, By Access
5.3 Procedure
5.3.1 Introduction
5.3.2 Interventional Cardiology
5.3.3 Interventional Radiology/Vascular Surgery
5.3.4 Y-o-Y Growth Analysis, By Procedure
5.3.5 Market Attractiveness Analysis, By Procedure
5.3.6 Market Share Analysis, By Procedure
5.4 End User
5.4.1 Introduction
5.4.2 Acute Care Facilities
5.4.3 Hospitals
5.4.4 Clinics
5.4.5 Y-o-Y Growth Analysis, By End User
5.4.5 Market Attractiveness Analysis, By End User
5.4.6 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 Type
6.1.3.3 By Access
6.1.3.4 By Procedure
6.1.3.5 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Type
6.1.4.3 By Access
6.1.4.4 By Procedure
6.1.4.5 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Type
6.1.5.3 By Access
6.1.5.4 By Procedure
6.1.5.5 By End User
6.2 Middle-East
6.3 Africa
7.Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.Market Leaders' Analysis
8.1 Merit Medical Systems, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Biotronik GMBH & CO.KG
8.3 Abbott Vascular
8.4 Cardinal Health
8.5 Medtronic
8.6 Boston Scientific Corporation
8.7 Cardival Medical, Inc.
8.8 Essential Medical, Inc.
8.9 W L. Gore & Associates
8.10 Scion BioMedical
8.11 St. Jude Medical
8.12 TZ Medical, Inc.
9.Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Talk to our analyst and get customised report done according to your research needs
Check if you can avail any discount. Submit your details and our team will get back to you.
Request to avail a free sample report that reflects this market and its growth.
